Hematology instruments include analyzers, flow cytometers, activity analyzers, and slide strainers. Hematology analyzers and reagents are used to perform white blood cell counts, complete blood counts, reticulocyte analysis, and coagulation tests. A recent report from Market Search Engine predicts that the global hematology analyzers and reagents market will exceed US $3.96 billion by 2022, growing at a CAGR of 5.2% during the forecast period 2016-2022.
The report identifies the factors boosting the growth of the market as:
- Increasing adoption of machine-driven hematology instruments
- Rising technological advancements
- Integration of basic flow-cytometry techniques in trendy hematology analyzers
- High-throughput hematology analyzers and
- Development of high-sensitivity point-of-care (POC) hematology testing
At the same time, factors such as high cost of instruments, low adoption of advanced hematology analyzers and reagents, product recall, highly competitive market for entrants, and several time consuming and stringent policies are expected to restrict the market’s growth.
End users of hematology reagents and analyzers cover Hospitals, Specialized Diagnostic Centers, Specialized Research Institutes, and Others.
Based on geographic segmentation, the market covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
Key participants operating in this global market include Abbott, Siemens AG, Beckman Coulter Inc., HORIBA, Ltd, Abaxis, Sysmex Corporation, Hoffmann-La Roche Ltd and others.